Healall Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-07-2024
- Paid Up Capital ₹ 2.00 M
as on 11-07-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 31.88%
(FY 2022)
- Profit 23.42%
(FY 2022)
- Ebitda -843.07%
(FY 2022)
- Net Worth 6.06%
(FY 2022)
- Total Assets 14.76%
(FY 2022)
About Healall Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mohinder Singh, Mohanbir Kaur, and Manita Kahai serve as directors at the Company.
- CIN/LLPIN
U51397PB2003PTC033447
- Company No.
033447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Healall Pharmaceuticals Private Limited offer?
Healall Pharmaceuticals Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Ammonium Compound, Ayurvedic,Herbal Products & Medicine, Herbal Piles Medicine, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Healall Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohinder Singh  | Director | 02-May-2003 | Current |
| Mohanbir Kaur | Director | 30-Dec-2004 | Current |
| Manita Kahai | Additional Director | 03-Sep-2009 | Current |
Financial Performance of Healall Pharmaceuticals.
Healall Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.88% increase. The company also saw a substantial improvement in profitability, with a 23.42% increase in profit. The company's net worth moved up by a moderate rise of 6.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healall Pharmaceuticals?
In 2018, Healall Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Healall Pharmaceuticals?
Healall Pharmaceuticals has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healall Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healall Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
